Interferon adjunct reduces MS lesions

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Interferon adjunct reduces MS lesions

Postby MSUK » Sun Jun 06, 2010 3:55 pm


The oral drug teriflunomide demonstrates short-term safety and reduces lesions in multiple sclerosis for up to one year when used in combination with interferon beta, according to a study presented here.

Treatment-emergent adverse events were similar to placebo for patients on combination therapy, and the relative risk reduction for gadolinium-enhancing lesions on active treatment was more than 80% at 1 year, compared to patients on interferon beta alone.... Read More - ... ageid/2933
User avatar
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 3:00 pm


Return to General Discussion


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service